Loading data...
Loading data...
Analyzing the stock…
70
Gathering technical, fundamental, and market data — a few seconds
Finance · ·
$39.03
▲ $0.06 (+0.2%)
Market data updated: 09/19 08:45 AM
Fundamentals updated: 09/19/2026
News analyzed: 09/19/2026
Market Cap
$5.57B
Day Range
$38.51 - $39.11
52-Week Range
$30.87 - $43.62
Beta
—
Next Earnings
21.10.2026
Support
$38.46
Resistance
$43.57
+6.8% (1Y)
Strengths: 5/22 factors positiveRisk: Medium
This score and all analysis on this page are for informational and educational purposes only and do not constitute investment advice. Read the full disclaimer
Weighted: Technical 25% · Fundamental 20% · Growth 15% · Valuation 15% · News 10% · Quality 10% · Risk 5%
Overall Score
🔴 Bearish
Technical Trend
🔴 Bearish
Computed directly from the same signals behind the score above — not AI-generated.
Biggest positive driver
Net income growth
Net income growth: 30.9%
Growth
Biggest negative driver
Calmar Ratio (return vs. drawdown)
Calmar: 0.21 (3y annualized return 9.6% / max drawdown 45.2%)
Risk
What to watch next
When today echoes the past.
NO RELIABLE ECHO FOUND
Only 2 historical analog(s) found after removing overlapping dates — too few for a statistically meaningful comparison.
Historical matches considered: 2
TIME ECHO identifies historical situations that resemble the current market state. Historical outcomes are not guarantees of future performance. Similarity does not imply causation, and results may change as new data becomes available.
🗓️ What Changed This Week
🌱 Building History
We don't have a real data point from a week ago for this stock yet. The weekly comparison will appear once enough history has accumulated.
📊 Score History
42
Today
—
30D
—
90D
—
1Y
🐂🐻 Investment Thesis
🐂 Bull Case
🐻 Bear Case
🔍 What Could Prove This Wrong
Not enough data yet to generate this synthesis.
This isn't a price-direction forecast — just a synthesis of real, already-computed data, and future conditions that could change the picture.
🧬 STOCK DNA
This stock's profile across 8 real dimensions — a research tool, not a recommendation
Growth
52
Quality
55
Value
50
Momentum
19
Risk
48
Sentiment
44
Fundamental
50
Institutional
No data available
Stocks with a similar DNA right now
Not enough comparably-scored stocks yet to show similar matches.
This stock hasn't been analyzed by StockIQAI's movement engine yet — coverage is still expanding. Check back soon.
Everyone's writing about Atlantic Union Bankshares Corporation. News trend score: 44. Reason: 6 of the last 20 articles are negative, versus 5 positive.
News trend analysis is based on article sentiment only, and is not investment advice or financial counsel. Read the full disclaimer
🌡️ Emotional Temperature
16
🎯 Conviction (vs. Emotion)
52
Psychology
71
Fundamentals
50
Technical
19
Valuation
50
The price is holding at a real, documented historical support/resistance level (a 50-day high or low).
A sharp drop, unusual volume, and negative news sentiment all at once — selling pressure that looks emotional.
Price, volume, and sentiment accelerating together — a sign investors are chasing the price, not just following it.
The stock is moving in lockstep with its peers at the same intensity, rather than on its own data.
Extreme momentum, price far above its moving average, and a large premium over fair value.
Price (3M)
-0%
Market Narrative
40
Fundamental Reality
52
Narrative Gap
-12
📈 4D Investor Psychology
Signal classification confidence: High (confidence in the behavioral read, not a price prediction). Describes observable market behavior, not what any individual investor thinks, and is not a buy/sell signal.
🏛️ Investor DNA — Historical Investors
A Historical Strategy Simulation: assuming each investor follows their documented principles, how would they rate this stock today? This is not a prediction of what they would actually do.
🟢 Best match
Edgar Lawrence Smith — 100/100
🔴 Weakest match
Peter Lynch — 29/100
🗣️ Why do they disagree?
Based on the documented principles of each investor, the model estimates that methodologies emphasizing long‑term buying power and cycle position—such as Smith, Nelson, Mackay and, to a lesser extent, Bagehot—assign very high scores, reflecting a view that the stock fits a decade‑scale, low‑mania profile. In contrast, approaches that weigh moderate valuation, risk pricing and disciplined risk‑reward, like Housel, Graham’s defensive stance, Marks, Schwager and Loeb, produce mid‑range scores, suggesting a cautious but still attractive case for patient holders. Finally, frameworks that stress trend direction, stringent cheapness criteria, growth quality or index‑efficiency—represented by Fisher, the efficient‑market view, Livermore, Graham’s enterprising criteria, Veblen and Lynch—rate the stock poorly, highlighting concerns over insufficient fundamentals, negative momentum, over‑growth and limited edge versus a broad market.
Edgar Lawrence Smith
Common Stocks as Long-Term Investments (1924)
🟢 100
Looks like a real 'buy and hold for a decade' candidate
Key question
Is this a stock I'd be happy to hold and forget about for a decade?
Fact → Principle → Simulation
Samuel Armstrong Nelson
The ABC of Stock Speculation (1903)
🟢 97
Cycle position looks favorable — closer to oversold than overbought
Key question
Is the price overextended, or is there still room to move?
Fact → Principle → Simulation
Charles Mackay
Extraordinary Popular Delusions and the Madness of Crowds (1841)
🟢 95
No obvious signs of crowd mania
Key question
Am I being swept along with the crowd, or thinking for myself?
Fact → Principle → Simulation
Walter Bagehot
Lombard Street (1873)
🟢 92
Not enough balance-sheet data for a real Bagehot read
Key question
Does this company have enough liquidity to survive real stress?
⚠️ Partial data for this stock — score is less reliable — Data availability: 25%
Fact → Principle → Simulation
Morgan Housel
The Psychology of Money (2020)
🟢 76
The kind of quiet compounder a patient holder could actually stick with
Key question
Could I live with this volatility long enough for compounding to actually work?
Fact → Principle → Simulation
Benjamin Graham
Security Analysis (1934) / The Intelligent Investor (1949)
🟢 74
Attractive to a Defensive Graham Investor
Key question
Where is my margin of safety?
Fact → Principle → Simulation
Howard Marks
The Most Important Thing (2011) / Mastering the Market Cycle (2018)
🟢 73
Risk appears reasonably priced — no obvious cycle-timing red flag
Key question
What is the market probably misunderstanding about the risk here?
Fact → Principle → Simulation
Jack Schwager
Market Wizards (1989)
🟢 69
A real, disciplined setup with favorable reward/risk
Key question
What's the risk/reward here, and where is my exit point?
Fact → Principle → Simulation
Howard Marks (Market Cycle)
Mastering the Market Cycle (2018)
🟢 69
Looks early-to-mid cycle, not overextended
Key question
Where are we in the cycle right now — near a hot extreme, or a cold one?
Fact → Principle → Simulation
Gerald M. Loeb
The Battle for Investment Survival (1935)
🟡 64
Moderate risk to capital
Key question
How much capital could I lose here if I'm wrong?
Fact → Principle → Simulation
Philip Fisher
Common Stocks and Uncommon Profits (1958)
🟡 50
Not enough fundamentals data for a real Fisher read
Key question
How exceptional is this business, really?
⚠️ Partial data for this stock — score is less reliable — Data availability: 0%
Burton Malkiel & John Bogle
A Random Walk Down Wall Street (1973) / The Little Book of Common Sense Investing (2007)
🟡 49
Mixed case — the evidence for picking this stock over an index is not strong
Key question
Do I actually have an edge here, or do I just think I do?
Fact → Principle → Simulation
Jesse Livermore
Reminiscences of a Stock Operator (1923) / How to Trade in Stocks (1940)
🟡 42
Negative trend — against Livermore's core rule of trading with the trend
Key question
What is the price telling me right now?
Fact → Principle → Simulation
Benjamin Graham (Enterprising Investor)
The Intelligent Investor (1949) — the Enterprising Investor chapters
🟡 39
Not statistically cheap enough for the Enterprising Investor's looser safety bar
Key question
Is the stock statistically cheap enough to justify the extra risk?
⚠️ Partial data for this stock — score is less reliable — Data availability: 45%
Fact → Principle → Simulation
Thorstein Veblen
The Theory of Business Enterprise (1904)
🔴 34
Pattern Veblen would flag as growth pursued for its own sake
Key question
Is management building real value, or just building itself?
⚠️ Partial data for this stock — score is less reliable — Data availability: 45%
Fact → Principle → Simulation
Peter Lynch
One Up on Wall Street (1989)
🔴 29
Doesn't clear Lynch's growth-at-a-reasonable-price bar
Key question
Is the growth worth the price?
⚠️ Partial data for this stock — score is less reliable — Data availability: 35%
Fact → Principle → Simulation
Based on the last 283 trading days, calculated from real price data. Click an indicator for details and a chart.
🔴 Most indicators support a downtrend (1 bullish · 10 bearish · 0 neutral)
A market-structure read based purely on real price and volume data — not full classic Wyckoff schematic identification (Phase A-E), but a quantitative analysis of what can reliably be computed: trading ranges, "effort vs. result", volume within the range, and Spring/Upthrust detection.
The stock is in a clear downtrend with no defined trading range in the period examined.
Medium confidence
The Wyckoff Method, developed by Richard Wyckoff in the early 20th century, reads the balance of supply and demand through price and volume, based on the premise that large investors ("smart money") quietly accumulate shares before rallies and quietly distribute them before declines. The read here is based solely on real price and volume data — full, precise identification of classic Wyckoff patterns (such as Phases A-E) requires human chart-reading experience and judgment, so this is an approximate algorithmic read, not a substitute for professional analysis. This should not be considered investment advice.
Gross Margin
—
Operating Margin
—
Net Margin
—
EBITDA Margin
—
ROE
5.5%
ROA
0.7%
ROIC
—
EPS
$2.03
Cash
$966.46M
Total Debt
$1.50B
Current Ratio
—
Debt/Equity
0.30
אין נתונים היסטוריים זמינים.
אין נתונים היסטוריים זמינים.
Total dividend per share paid each year, over the last 5 years.
| Ex-Dividend Date | Amount per Share |
|---|---|
| 7.8.2026 | $0.370 |
| 22.5.2026 | $0.370 |
| 21.5.2026 | $0.370 |
| 13.2.2026 | $0.370 |
| 12.2.2026 | $0.370 |
| 14.11.2025 | $0.370 |
| 13.11.2025 | $0.370 |
| 4.8.2025 | $0.340 |
| 3.8.2025 | $0.340 |
| 23.5.2025 | $0.340 |
| 22.5.2025 | $0.340 |
| 14.2.2025 | $0.340 |
How is Fair Value calculated? →
Not enough cash-flow data to calculate a DCF model for this stock.
Book Value per Share
$38.76
Tangible Book Value per Share (Tangible NAV)
$22.90
Sentiment based on basic keywords (not AI) — 5 positive, 9 neutral, 6 negative out of the last 20 articles.
Yahoo · 11.9.2026
Zacks · 11.9.2026
SeekingAlpha · 31.7.2026
Business Wire · 23.7.2026
Yahoo · 23.7.2026
Moby · 22.7.2026
Benzinga · 22.7.2026
Yahoo · 22.7.2026
Simply Wall St. · 22.7.2026
Yahoo · 21.7.2026
MarketBeat · 21.7.2026
Zacks · 21.7.2026
Zacks · 21.7.2026
InvestorsHub · 21.7.2026
MT Newswires · 21.7.2026
Associated Press · 21.7.2026
SeekingAlpha · 21.7.2026
SeekingAlpha · 21.7.2026
ChartMill · 21.7.2026
Benzinga · 21.7.2026
Atlantic Union Bankshares Corporation (AUB) currently has a StockIQ AI score of 42/100, rated "Weak". The score is a weighted average across up to 7 categories (technical, fundamental, growth, fair value, news, quality, risk), based on real data only.
AUB currently scores 42/100 (Weak) across the categories we measure. StockIQ doesn't give buy/sell recommendations — use this as one data point in your own research, not as investment advice.
AUB's technical score is 19/100, which currently reads as bearish — based on real price/volume signals (moving averages, RSI, MACD, and more), not a prediction of what happens next.
Based on the real signals StockIQ computed: Net income growth: 30.9%; Debt/equity: 0.30; Price is above the 200-day average.
Based on the real signals StockIQ computed: Calmar: 0.21 (3y annualized return 9.6% / max drawdown 45.2%); Earnings per share (EPS) growth: -9.4%; Price is below the 50-day average.
Yes — AUB has a real recorded dividend payment history on StockIQ. See the Dividends section on this page for the actual per-share amounts and dates.
Real transactions by officers and insiders, as reported to the SEC on Form 4 — 0 purchases and 0 sales out of the last 25 filings.
| Name | Transaction Type | Date | Shares | Change | Price |
|---|---|---|---|---|---|
| Engola Paul | Grant/Award from Employer | 1.7.2026 | 9,134 | +827 | — |
| MCCANN PATRICK J | Grant/Award from Employer | 1.7.2026 | 33,658 | +473 | — |
| O'Hara Michelle A. | Grant/Award from Employer | 1.7.2026 | 5,944 | +473 | — |
| SCHREINER LINDA V | Grant/Award from Employer | 1.7.2026 | 25,488 | +473 | — |
| Wimbush Frederick Blair | Grant/Award from Employer | 1.7.2026 | 13,742 | +473 | $42.31 |
| WAMPLER KEITH L | Grant/Award from Employer | 1.7.2026 | 20,647 | +473 | — |
| Delorier Rilla S | Grant/Award from Employer | 1.7.2026 | 9,216 | +473 | — |
| KIMBLE DONALD R | Grant/Award from Employer | 1.7.2026 | 12,944 | +473 | — |
| SCHRIDER DANIEL J | Grant/Award from Employer | 1.7.2026 | 179,817 | +473 | — |
| TILLETT RONALD L | Grant/Award from Employer | 1.7.2026 | 11,422 | +473 | $42.31 |
| AGEE NANCY H | Grant/Award from Employer | 1.7.2026 | 38,624 | +827 | — |
| Ellett Frank Russell | Grant/Award from Employer | 1.7.2026 | 81,837 | +827 | — |
| Micklem Mark C | Grant/Award from Employer | 1.7.2026 | 22,736 | +473 | — |
| Stephenson Mona Abutaleb | Grant/Award from Employer | 1.7.2026 | 14,325 | +473 | — |
| SHEPHARD JOEL R | Grant/Award from Employer | 1.7.2026 | 4,039 | +473 | $42.31 |
| SCHREINER LINDA V | Grant/Award from Employer | 1.7.2026 | 473 | +473 | — |
| Wimbush Frederick Blair | Grant/Award from Employer | 1.7.2026 | 473 | +473 | $42.31 |
| TILLETT RONALD L | Grant/Award from Employer | 1.7.2026 | 473 | +473 | $42.31 |
| O'Hara Michelle A. | Grant/Award from Employer | 1.7.2026 | 473 | +473 | — |
| SCHRIDER DANIEL J | Grant/Award from Employer | 1.7.2026 | 473 | +473 | — |
| Stephenson Mona Abutaleb | Grant/Award from Employer | 1.7.2026 | 473 | +473 | — |
| Engola Paul | Grant/Award from Employer | 1.7.2026 | 827 | +827 | — |
| Micklem Mark C | Grant/Award from Employer | 1.7.2026 | 473 | +473 | — |
| KIMBLE DONALD R | Grant/Award from Employer | 1.7.2026 | 473 | +473 | — |
| WAMPLER KEITH L | Grant/Award from Employer | 1.7.2026 | 473 | +473 | — |
Official FINRA data — the number of shares open in short positions, plus daily short-sale activity.
7,558,598 shares short as of 2026-08-31 · vs. 7,476,530 on 2026-07-31
Official biweekly report (FINRA Rule 4560) — no real higher-frequency data exists for this metric.
54.5% of trading volume this week was short selling, vs. 37.5% the prior week
Based on daily short-sale volume (Reg SHO) — a different metric from the open short interest above: this is daily trading volume, not an open position, so it updates weekly rather than biweekly.
Full breakdown of every data type and its source: Data Sources · Methodology